Stepan Company reported a strong start to 2025 with significant increases in net income and operating income, driven by volume growth across its Surfactants, Polymers, and Specialty Products segments. Despite negative free cash flow due to working capital investments, the company remains cautiously optimistic for full-year growth and positive free cash flow.
Net income increased 42% to $19.7 million, and operating income rose 40% to $28.3 million year-over-year.
Overall sales volume grew 4%, with Surfactants, Polymers, and Specialty Products all contributing to the increase.
Adjusted EBITDA saw a 12% increase, reaching $57.5 million, primarily driven by performance in the Surfactant and Specialty Product businesses.
Free cash flow was negative $25.8 million for the quarter, impacted by higher working capital to support growth and anticipation of tariffs.
Stepan remains focused on accelerating business strategies to drive volume growth, improve product mix, and enhance free cash flow generation. They are cautiously optimistic for full-year adjusted EBITDA and adjusted net income growth and positive free cash flow in 2025.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance